PDK4 and lung carcinoma: Trinidad et al. [92] found that knockout of PDK4 could down-regulate the expression of the mutant oncogene KRAS, thereby inhibiting cell growth of lung cancer and colorectal cancer (CRC) cells, indicating that PDK4 is an attractive target for cancer treatment.